Multiple Sclerosis Drugs Market Pipeline Developments and Emerging Therapies | #multiple sclerosis therapies # oral MS drugs # remyelination biologics # S1P modulators # personalized neurology # AI in MS treatment # at‑home MS therapy # subcutaneous MS medications # neuroprotection drugs # MS relapse prevention

מדע וטכנולוגיה

Multiple Sclerosis Drugs Market Pipeline Developments and Emerging Therapies

The Global Multiple Sclerosis Drugs Market size is expected to be worth around USD 41 Billion by 2032 from USD 28.2 Billion in 2022, growing at a CAGR of 3.8% during the forecast period from 2022 to 2032.